HEPA logo

Hepion Pharmaceuticals (HEPA) Working Capital

Annual Working Capital

$12.20 M
-$36.41 M-74.91%

31 December 2023

HEPA Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Working Capital

$814.30 K
-$3.69 M-81.93%

30 September 2024

HEPA Quarterly Working Capital Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

HEPA Working Capital Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-74.9%-94.5%
3 y3 years-67.9%-99.2%
5 y5 years+10000.0%-94.0%

HEPA Working Capital High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-86.3%at low-99.2%at low
5 y5 years-86.3%>+9999.0%-99.3%at low
alltimeall time-86.3%+8781.6%-99.3%+136.1%

Hepion Pharmaceuticals Working Capital History

DateAnnualQuarterly
Sept 2024
-
$814.30 K(-81.9%)
June 2024
-
$4.51 M(-64.9%)
Mar 2024
-
$12.86 M(+5.4%)
Dec 2023
$12.20 M(-74.9%)
$12.20 M(-18.0%)
Sept 2023
-
$14.87 M(-40.7%)
June 2023
-
$25.09 M(-30.3%)
Mar 2023
-
$36.01 M(-25.9%)
Dec 2022
$48.61 M(-45.5%)
$48.61 M(-16.4%)
Sept 2022
-
$58.18 M(-12.1%)
June 2022
-
$66.16 M(-20.8%)
Mar 2022
-
$83.51 M(-6.4%)
Dec 2021
$89.25 M(+135.0%)
$89.25 M(-9.3%)
Sept 2021
-
$98.42 M(-7.7%)
June 2021
-
$106.57 M(-7.2%)
Mar 2021
-
$114.88 M(+202.5%)
Dec 2020
$37.97 M(+197.1%)
$37.97 M(+265.2%)
Sept 2020
-
$10.40 M(-33.2%)
June 2020
-
$15.57 M(-1.3%)
Mar 2020
-
$15.77 M(+23.4%)
Dec 2019
$12.78 M(>+9900.0%)
$12.78 M(-6.6%)
Sept 2019
-
$13.68 M(-12.3%)
June 2019
-
$15.59 M(-1110.1%)
Mar 2019
-
-$1.54 M(-1405.8%)
DateAnnualQuarterly
Dec 2018
$118.20 K(-96.6%)
$118.20 K(-96.6%)
Sept 2018
-
$3.50 M(-255.1%)
June 2018
-
-$2.26 M(-242.4%)
Mar 2018
-
$1.59 M(-74.1%)
Dec 2017
$3.46 M(-66.3%)
-
Sept 2017
-
$6.13 M(-40.2%)
June 2017
$10.25 M(+264.5%)
$10.25 M(+150.9%)
Mar 2017
-
$4.09 M(-46.5%)
Dec 2016
-
$7.63 M(-593.0%)
Sept 2016
-
-$1.55 M(-155.1%)
June 2016
$2.81 M(-15.0%)
$2.81 M(+20.3%)
Mar 2016
-
$2.34 M(-65.4%)
Dec 2015
-
$6.76 M(-551.9%)
Sept 2015
-
-$1.50 M(-145.2%)
June 2015
$3.31 M(+117.0%)
$3.31 M(-57.3%)
Mar 2015
-
$7.75 M(-8.8%)
Dec 2014
-
$8.49 M(+1880.5%)
Sept 2014
-
$428.70 K(-71.9%)
June 2014
$1.52 M(-1184.3%)
$1.52 M(-35.7%)
Mar 2014
-
$2.37 M(-583.3%)
Dec 2013
-
-$489.90 K(+51.9%)
Sept 2013
-
-$322.60 K
June 2013
-$140.50 K
-

FAQ

  • What is Hepion Pharmaceuticals annual working capital?
  • What is the all time high annual working capital for Hepion Pharmaceuticals?
  • What is Hepion Pharmaceuticals annual working capital year-on-year change?
  • What is Hepion Pharmaceuticals quarterly working capital?
  • What is the all time high quarterly working capital for Hepion Pharmaceuticals?
  • What is Hepion Pharmaceuticals quarterly working capital year-on-year change?

What is Hepion Pharmaceuticals annual working capital?

The current annual working capital of HEPA is $12.20 M

What is the all time high annual working capital for Hepion Pharmaceuticals?

Hepion Pharmaceuticals all-time high annual working capital is $89.25 M

What is Hepion Pharmaceuticals annual working capital year-on-year change?

Over the past year, HEPA annual working capital has changed by -$36.41 M (-74.91%)

What is Hepion Pharmaceuticals quarterly working capital?

The current quarterly working capital of HEPA is $814.30 K

What is the all time high quarterly working capital for Hepion Pharmaceuticals?

Hepion Pharmaceuticals all-time high quarterly working capital is $114.88 M

What is Hepion Pharmaceuticals quarterly working capital year-on-year change?

Over the past year, HEPA quarterly working capital has changed by -$14.05 M (-94.52%)